{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:24:45Z","timestamp":1790623485308,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.vph.2017.11.001","type":"journal-article","created":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T02:33:09Z","timestamp":1510021989000},"page":"51-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Endothelium-derived contraction in a model of rheumatoid arthritis is mediated via angiotensin II type 1 receptors"],"prefix":"10.1016","volume":"100","author":[{"given":"Kayleigh","family":"Hamilton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette","family":"Dunning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Ferrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Lockhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"MacKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vph.2017.11.001_bb0005","first-page":"445","article-title":"Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden","volume":"24","author":"Wallberg-Jonsson","year":"1997","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.vph.2017.11.001_bb0010","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.1780370408","article-title":"The mortality of rheumatoid arthritis","volume":"37","author":"Wolfe","year":"1994","journal-title":"Arthritis Rheum."},{"issue":"24","key":"10.1016\/j.vph.2017.11.001_bb0015","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \"high-grade\" systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.vph.2017.11.001_bb0020","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.24836","article-title":"Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study","volume":"61","author":"Peters","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.vph.2017.11.001_bb0025","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1136\/ard.2005.050377","article-title":"Patterns of cardiovascular risk in rheumatoid arthritis","volume":"65","author":"Solomon","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.vph.2017.11.001_bb0030","doi-asserted-by":"crossref","DOI":"10.1111\/1756-185X.12999","article-title":"New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis","author":"Mahmoudi","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.vph.2017.11.001_bb0035","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nrrheum.2015.40","article-title":"Atherosclerosis in rheumatoid arthritis: is it all about inflammation?","volume":"11","author":"Skeoch","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"issue":"6","key":"10.1016\/j.vph.2017.11.001_bb0040","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1253\/circj.CJ-09-0274","article-title":"Rheumatoid arthritis: model of systemic inflammation driving atherosclerosis","volume":"73","author":"Ku","year":"2009","journal-title":"Circ. J."},{"issue":"2","key":"10.1016\/j.vph.2017.11.001_bb0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/cei.12467","article-title":"Angiotensin II in inflammation, immunity and rheumatoid arthritis","volume":"179","author":"Chang","year":"2015","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.vph.2017.11.001_bb0050","first-page":"RA194","article-title":"Angiotensin II and vascular inflammation","volume":"11","author":"Cheng","year":"2005","journal-title":"Med. Sci. Monit."},{"issue":"7","key":"10.1016\/j.vph.2017.11.001_bb0055","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.tips.2008.05.003","article-title":"Role of the renin-angiotensin system in vascular inflammation","volume":"29","author":"Marchesi","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.vph.2017.11.001_bb0060","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00041552-200105000-00005","article-title":"Proinflammatory actions of angiotensins","volume":"10","author":"Ruiz-Ortega","year":"2001","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"3","key":"10.1016\/j.vph.2017.11.001_bb0065","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4331\/wjbc.v6.i3.209","article-title":"Inflammation, oxidative stress and renin angiotensin system in atherosclerosis","volume":"6","author":"Husain","year":"2015","journal-title":"World J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.vph.2017.11.001_bb0070","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.pharmthera.2010.11.001","article-title":"Endothelium-derived vasoactive agents, AT1 receptors and inflammation","volume":"131","author":"MacKenzie","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.vph.2017.11.001_bb0075","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/689360","article-title":"The renin-angiotensin-aldosterone system in vascular inflammation and remodeling","volume":"2014","author":"Pacurari","year":"2014","journal-title":"Int J Inflam"},{"issue":"2","key":"10.1016\/j.vph.2017.11.001_bb0080","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/art.22335","article-title":"Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis: in vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitis","volume":"56","author":"Price","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"23","key":"10.1016\/j.vph.2017.11.001_bb0085","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.lfs.2013.04.011","article-title":"Angiotensin II type 1 receptor blockade protects endothelium-derived hyperpolarising factor-mediated relaxation in a rat model of monoarthritis","volume":"92","author":"Mackenzie","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.vph.2017.11.001_bb0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.peptides.2013.05.012","article-title":"Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis","volume":"46","author":"Silveira","year":"2013","journal-title":"Peptides"},{"issue":"6","key":"10.1016\/j.vph.2017.11.001_bb0095","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/art.21040","article-title":"Angiotensin receptor blockers suppress antigen-specific T cell responses and ameliorate collagen-induced arthritis in mice","volume":"52","author":"Sagawa","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.vph.2017.11.001_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/648537","article-title":"Expression of angiotensin II Receptor-1 in human articular chondrocytes","volume":"2012","author":"Kawakami","year":"2012","journal-title":"Arthritis"},{"issue":"2","key":"10.1016\/j.vph.2017.11.001_bb0105","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1476-5381.1994.tb13091.x","article-title":"AT1 receptor characteristics of angiotensin analogue binding in human synovium","volume":"112","author":"Walsh","year":"1994","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.vph.2017.11.001_bb0110","first-page":"613","article-title":"Plasma renin activity as a marker of renovascular injury in patients with rheumatoid arthritis","volume":"14","author":"Mavrikakis","year":"1996","journal-title":"Clin. Exp. Rheumatol."},{"issue":"17","key":"10.1016\/j.vph.2017.11.001_bb0115","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/CIRCULATIONAHA.107.734384","article-title":"Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis","volume":"117","author":"Flammer","year":"2008","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.vph.2017.11.001_bb0120","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Inflammation in atherosclerosis: from pathophysiology to practice","volume":"54","author":"Libby","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.vph.2017.11.001_bb0125","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00059-008-3088-2","article-title":"The endothelium - the cardiovascular health barometer","volume":"33","author":"Herrmann","year":"2008","journal-title":"Herz"},{"issue":"5","key":"10.1016\/j.vph.2017.11.001_bb0130","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s003950050156","article-title":"Endothelial cell functions. Relationship to atherogenesis","volume":"94","author":"Toborek","year":"1999","journal-title":"Basic Res. Cardiol."},{"issue":"1","key":"10.1016\/j.vph.2017.11.001_bb0135","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/ar4450","article-title":"Mechanisms of endothelial dysfunction in rheumatoid arthritis: lessons from animal studies","volume":"16","author":"Totoson","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"10 Suppl. 1","key":"10.1016\/j.vph.2017.11.001_bb0140","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.amjmed.2008.06.014","article-title":"Role of inflammation in atherosclerosis associated with rheumatoid arthritis","volume":"121","author":"Libby","year":"2008","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.vph.2017.11.001_bb0145","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.20878","article-title":"Cardiovascular death in rheumatoid arthritis: a population-based study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.vph.2017.11.001_bb0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/ard.2003.007740","article-title":"Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity","volume":"63","author":"Vaudo","year":"2004","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.vph.2017.11.001_bb0155","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00424-009-0783-7","article-title":"Human endothelial dysfunction: EDCFs","volume":"459","author":"Virdis","year":"2010","journal-title":"Pflugers Arch."},{"issue":"9","key":"10.1016\/j.vph.2017.11.001_bb0160","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/aps.2010.127","article-title":"COX-mediated endothelium-dependent contractions: from the past to recent discoveries","volume":"31","author":"Wong","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.vph.2017.11.001_bb0165","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1753-0407.2009.00030.x","article-title":"Reactive oxygen-derived free radicals are key to the endothelial dysfunction of diabetes","volume":"1","author":"Shi","year":"2009","journal-title":"J Diabetes"},{"issue":"1","key":"10.1016\/j.vph.2017.11.001_bb0170","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11906-006-0045-4","article-title":"Endothelium, aging, and hypertension","volume":"8","author":"Taddei","year":"2006","journal-title":"Curr. Hypertens. Rep."},{"issue":"Pt 22","key":"10.1016\/j.vph.2017.11.001_bb0175","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1113\/jphysiol.2008.161430","article-title":"Endothelium-dependent contractions: when a good guy turns bad!","volume":"586","author":"Vanhoutte","year":"2008","journal-title":"J. Physiol."},{"issue":"7","key":"10.1016\/j.vph.2017.11.001_bb0180","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.vph.2017.11.001_bb0185","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","article-title":"Guidelines for reporting experiments involving animals: the ARRIVE guidelines","volume":"160","author":"McGrath","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.vph.2017.11.001_bb0190","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1136\/ard.2003.017269","article-title":"Divergent roles of nitrergic and prostanoid pathways in chronic joint inflammation","volume":"63","author":"Day","year":"2004","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.vph.2017.11.001_bb0195","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/CH-2009-1154","article-title":"Erythrocyte aggregation in rheumatoid arthritis: cell and plasma factor's role","volume":"41","author":"Luquita","year":"2009","journal-title":"Clin. Hemorheol. Microcirc."},{"issue":"8","key":"10.1016\/j.vph.2017.11.001_bb0200","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.3899\/jrheum.081188","article-title":"Which measure of inflammation to use? A comparison of erythrocyte sedimentation rate and C-reactive protein measurements from randomized clinical trials of golimumab in rheumatoid arthritis","volume":"36","author":"Crowson","year":"2009","journal-title":"J. Rheumatol."},{"issue":"10","key":"10.1016\/j.vph.2017.11.001_bb0205","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/01.ATV.0000033516.73864.4E","article-title":"Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis","volume":"22","author":"Bergholm","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.vph.2017.11.001_bb0210","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.00036.2005","article-title":"Physiology of local renin-angiotensin systems","volume":"86","author":"Paul","year":"2006","journal-title":"Physiol. Rev."},{"issue":"8","key":"10.1016\/j.vph.2017.11.001_bb0215","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/sj.bjp.0705877","article-title":"Indomethacin potentiates acetylcholine-induced vasodilation by increasing free radical production","volume":"142","author":"De Angelis","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.vph.2017.11.001_bb0220","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejphar.2007.08.011","article-title":"Pharmacological nature of nicotine-induced contraction in the rat basilar artery: involvement of arachidonic acid metabolites","volume":"577","author":"Ji","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.vph.2017.11.001_bb0225","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1476-5381.2010.00957.x","article-title":"Pharmacological modulation by celecoxib of cachexia associated with experimental arthritis and atherosclerosis in rabbits","volume":"161","author":"Romero","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.vph.2017.11.001_bb0230","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/ar3860","article-title":"Treatment with the arginase inhibitor Nw-hydroxy-nor-L-arginine restores endothelial function in rat adjuvant-induced arthritis","volume":"14","author":"Prati","year":"2012","journal-title":"Arthritis Res. Ther"},{"issue":"8","key":"10.1016\/j.vph.2017.11.001_bb0235","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/sj.bjp.0706423","article-title":"Hydrogen peroxide is an endothelium-dependent contracting factor in rat renal artery","volume":"146","author":"Gao","year":"2005","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.vph.2017.11.001_bb0240","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/sj.bjp.0704669","article-title":"Oxygen-derived free radicals mediate endothelium-dependent contractions to acetylcholine in aortas from spontaneously hypertensive rats","volume":"136","author":"Yang","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2017.11.001_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2010.03.003","article-title":"Mechanisms underlying the losartan treatment-induced improvement in the endothelial dysfunction seen in mesenteric arteries from type 2 diabetic rats","author":"Matsumoto","year":"2010","journal-title":"Pharmacol. Res."},{"issue":"13","key":"10.1016\/j.vph.2017.11.001_bb0250","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1111\/bph.12677","article-title":"Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation","volume":"171","author":"Bauer","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.vph.2017.11.001_bb0255","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pharmthera.2009.02.006","article-title":"Prostanoids and reactive oxygen species: team players in endothelium-dependent contractions","volume":"122","author":"Tang","year":"2009","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.vph.2017.11.001_bb0260","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00424-010-0786-4","article-title":"Endothelial dysfunction: a strategic target in the treatment of hypertension?","volume":"459","author":"Tang","year":"2010","journal-title":"Pflugers Arch."},{"issue":"1","key":"10.1016\/j.vph.2017.11.001_bb0265","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/ars.2011.4335","article-title":"Reciprocal relationship between reactive oxygen species and cyclooxygenase-2 and vascular dysfunction in hypertension","volume":"18","author":"Martinez-Revelles","year":"2013","journal-title":"Antioxid. Redox Signal."},{"issue":"2","key":"10.1016\/j.vph.2017.11.001_bb0270","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00005344-199808000-00005","article-title":"Losartan inhibits thromboxane A2-induced platelet aggregation and vascular constriction in spontaneously hypertensive rats","volume":"32","author":"Li","year":"1998","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"5","key":"10.1016\/j.vph.2017.11.001_bb0275","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/art.27384","article-title":"Involvement of the renin-angiotensin system in the development of vascular damage in a rat model of arthritis: effect of angiotensin receptor blockers","volume":"62","author":"Sakuta","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"Pt 2","key":"10.1016\/j.vph.2017.11.001_bb0280","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1113\/jphysiol.2004.062984","article-title":"Pathophysiology of vascular dysfunction in a rat model of chronic joint inflammation","volume":"557","author":"Egan","year":"2004","journal-title":"J. Physiol."},{"key":"10.1016\/j.vph.2017.11.001_bb0285","doi-asserted-by":"crossref","first-page":"401690","DOI":"10.1155\/2015\/401690","article-title":"Validity and agreement between the 28-joint disease activity score based on C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis","volume":"2015","author":"Nielung","year":"2015","journal-title":"Arthritis"},{"issue":"4","key":"10.1016\/j.vph.2017.11.001_bb0290","first-page":"600","article-title":"Studies on the antithrombotic action of AT1 receptor antagonists","volume":"7","author":"Buczko","year":"2001","journal-title":"Med. Sci. Monit."},{"issue":"3","key":"10.1016\/j.vph.2017.11.001_bb0295","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00004872-199917030-00019","article-title":"Effect of losartan on human platelet activation","volume":"17","author":"Guerra-Cuesta","year":"1999","journal-title":"J. Hypertens."},{"issue":"6","key":"10.1016\/j.vph.2017.11.001_bb0300","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/hr.2014.22","article-title":"Antithrombotic effects of losartan in patients with hypertension complicated by atrial fibrillation: 4A (angiotensin II antagonist of platelet aggregation in patients with atrial fibrillation), a pilot study","volume":"37","author":"Sakamoto","year":"2014","journal-title":"Hypertens. Res."},{"issue":"11","key":"10.1016\/j.vph.2017.11.001_bb0305","first-page":"FC14","article-title":"A pilot study on the effect of angiotensin receptor blockers on platelet aggregation in hypertensive patients- a prospective observational study","volume":"10","author":"Suresh","year":"2016","journal-title":"J. Clin. Diagn. Res."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189117302653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189117302653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T05:59:12Z","timestamp":1603259952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189117302653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":61,"alternative-id":["S1537189117302653"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2017.11.001","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endothelium-derived contraction in a model of rheumatoid arthritis is mediated via angiotensin II type 1 receptors","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2017.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2017 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}